Old Web
English
Sign In
Acemap
>
authorDetail
>
Hassan Shehata
Hassan Shehata
North Carolina Central University
Cancer
Glioma
Harmine
Monoamine oxidase A
Kinase
3
Papers
2
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Identification of harmine and β-carboline analogs from a high-throughput screen of an approved drug collection; profiling as differential inhibitors of DYRK1A and monoamine oxidase A and for in vitro and in vivo anti-cancer studies.
2021
European Journal of Pharmaceutical Sciences
Michael Tarpley
Helen O. Oladapo
Dillon Strepay
Thomas B. Caligan
Lhoucine Chdid
Hassan Shehata
Jose R. Roques
Rhashad Thomas
Christopher P Laudeman
Rob U. Onyenwoke
David B. Darr
Kevin P. Williams
Show All
Source
Cite
Save
Citations (2)
Abstract A138: Profiling of harmine and select analogs as differential inhibitors of DYRK1A and monoamine oxidase A: Exploring the potential for anti-cancer efficacy and minimizing off-target activity
2019
Molecular Cancer Therapeutics
Hassan Shehata
Michael Tarpley
Helen Oladapo
Dillon Strepay
Jose R. Roques
Rob U. Onyenwoke
David B. Darr
Kevin P. Williams
Show All
Source
Cite
Save
Citations (0)
Abstract B47: Efficacy of GLI antagonists in triple-negative inflammatory breast cancer 2D and 3D models
2018
Cancer Epidemiology, Biomarkers & Prevention
Helen Oladapo
Xiaojia Ji
Hassan Shehata
Mike Tarpley
Lhoucine Chdid
David R. Lamson
Xuhui Bao
Scott J. Sauer
Gayathri R. Devi
Kevin P. Williams
Show All
Source
Cite
Save
Citations (0)
1